M&A

Novartis to buy French cancer specialist AAA for $3.9 billion
Yahoo/Reuters
Mon, 10/30/17 - 09:58 am
Novartis
M&A
France
Advanced Accelerator Application
radiopharmaceuticals
oncology
In a switch, Merck CEO signals he’s in a deal-making frame of mind
Endpoints
Fri, 10/27/17 - 11:18 am
Merck
M&A
Pharma CEOs
Ken Frazier
Why CVS Won't Buy Aetna
Forbes
Fri, 10/27/17 - 11:03 am
CVS Health
M&A
Aetna
Anthem
PBMs
Sanofi, J&J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report
Fierce Pharma
Thu, 10/26/17 - 10:58 am
Sanofi
JNJ
GSK
Reckitt Benckiser
Pfizer
M&A
consumer health
OTC
PDL gets aggressive with an offer to buy out Neos Therapeutics
Endpoints
Thu, 10/26/17 - 10:44 am
PDL Biopharma
Neos Therapeutics
M&A
Reader poll: Pfizer most likely buyer for Spark
Biopharma Dive
Wed, 10/25/17 - 10:39 pm
Pfizer
Spark Therapeutics
M&A
Stryker to acquire French spinal implant maker Vexim for $216m
Mass Device
Wed, 10/25/17 - 10:15 pm
Stryker
M&A
Vexim
spinal implants
devices
GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?
Fierce Pharma
Wed, 10/25/17 - 10:13 pm
GSK
M&A
Pfizer
OTC
consumer health
GSK to study consumer health buys but pharma top priority
Yahoo/Reuters
Wed, 10/25/17 - 09:43 am
GSK
consumer health
M&A
The Worrisome 'Why' Behind Eli Lilly's Change of Heart
Bloomberg
Tue, 10/24/17 - 05:41 pm
Eli Lilly
M&A
Elanco
animal health
Eli Lilly Considering IPO or Sale of Its Elanco Animal Health Business
TheStreet.com
Tue, 10/24/17 - 10:14 am
Eli Lilly
IPOs
Elanco
animal health
M&A
Without tax reform, pharma M&A's still sluggish—but biotech's red hot
Fierce Pharma
Sat, 10/21/17 - 10:19 am
M&A
biotech
pharma industry
Biopharma, medical M&A activity slows in 2017: report
Biopharma Dive
Thu, 10/19/17 - 12:05 pm
M&A
Troubled Orexigen looks for a buyer, but will anyone want Contrave?
Fierce Pharma
Thu, 10/19/17 - 11:33 am
Orexigen Therapeutics
Contrave
M&A
Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns
Endpoints
Tue, 10/17/17 - 09:50 am
Orexigen
Contrave
M&A
Things Get Ugly Between NuVasive and Alphatec
Medical Device and Diagnostic Industry
Sat, 10/14/17 - 10:57 am
NuVasive
Alphatec
devices
M&A
Reckitt Benckiser is the most likely buyer of Pfizer’s Consumer Healthcare business
GoinPharma
Fri, 10/13/17 - 11:57 am
Reckitt Benckiser
Pfizer
M&A
consumer health
3 Signs Myriad Genetics' High-Growth Days Are Over
Motley Fool
Thu, 10/12/17 - 09:18 am
Myriad Genetics
M&A
competition
3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff
Motley Fool
Wed, 10/11/17 - 09:55 am
Pfizer
consumer health
M&A
Express Scripts drops $3.6B for healthcare management company
Biopharma Dive
Tue, 10/10/17 - 11:19 pm
Express Scripts
M&A
healthcare management
eviCore

Pages